Mesenchymal stem cell-derived interleukin-28 drives the selection of apoptosis resistant bone metastatic prostate cancer

Jeremy McGuire(University of South Florida), Conor C. Lynch(Moffitt Cancer Center)
Nature Communications
February 1, 2021
Cited by 52


Related Papers